FFA
CRMD icon

Farther Finance Advisors’s CorMedix CRMD Stock Holding History

Farther Finance Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.74K Sell
875
-185
-17% -$1.48K ﹤0.01% 4842
2026
Q2 		$8.32K Buy
1,060
+993
+1,482% +$7.84K ﹤0.01% 4544
2026
Q1 		$470 Sell
67
-49
-42% -$362 ﹤0.01% 5285
2025
Q4 		$1.35K Buy
116
+39
+51% +$431 ﹤0.01% 4824
2025
Q3 		$896 Buy
77
+25
+48% +$302 ﹤0.01% 4398
2025
Q2 		$641 Hold
52
– – ﹤0.01% 3998
2025
Q1 		$316 Hold
52
– – ﹤0.01% 3859
2024
Q4 		$421 Hold
52
– – ﹤0.01% 3473
2024
Q3 		$420 Hold
52
– – ﹤0.01% 3467
2024
Q2 		$223 Hold
52
– – ﹤0.01% 3479
2024
Q1 		$217 Sell
52
-54
-51% -$187 ﹤0.01% 3253
2023
Q4 		$399 Buy
+106
New +$365 ﹤0.01% 3043

Other funds holding CRMD

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Farther Finance Advisors's CRMD Position: Q3 2026 in Review

Farther Finance Advisors reduced its CorMedix (CRMD) stake by 17% in Q3 2026, selling an estimated $1.48K and leaving 875 shares worth $6.74K. The position accounts for ﹤0.01% of the portfolio, ranked #4842.

Farther Finance Advisors first reported a position in CRMD in Q4 2023 and has held it in 12 quarters since. The position peaked at $8.32K in Q2 2026. 6 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.

  • Farther Finance Advisors held 875 shares of CorMedix worth $6.74K as of Q3 2026.
  • Farther Finance Advisors sold 185 CorMedix shares in Q3 2026, an estimated $1.48K.
  • CorMedix made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4842 holding.
  • Farther Finance Advisors first reported a position in CorMedix in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's CorMedix position peaked at $8.32K in Q2 2026.
  • 6 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.